Safety and feasibility assessment of implantable chest wall venous access port for patients with acute leukemia

Key Points

• TIVAP can provide a safe and effective long-term intravenous treatment for acute leukemia.
• In patients with acute leukemia, TIVAP demonstrates safety and feasibility for venous access.
• Observational analysis of TIVAP supports its use for prolonged intravenous therapy in patients.
• The findings may suggest TIVAP as a standard option for managing treatment in acute leukemia cases.